Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00684086 · ClinicalTrials.gov registry record · NA

English Diabetes Self-Management Program

A NA study of Diabetes Mellitus, Type 2, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT00684086 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Stanford University. The registered enrollment target is 350 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00684086, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

We propose a diabetes self-management program evaluation and dissemination project with three components. 1. A six-month randomized trial to evaluate the effect of a community-based small group Diabetes Self Management Program (DSMP) on the health related quality of life, metabolic control and health care utilization of people with type 2 diabetes. 2. A long-term (12 month) longitudinal evaluation of the same program. 3. Two 5 day workshops to train others in California in how to lead and administer the program.

Conditions Studied

Interventions

  • BEHAVIORAL Diabetes Self Management Program

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2007-04
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00684086

The ClinicalTrials.gov registry entry for NCT00684086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Self Management Program is the first listed.

NCT00684086 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00684086 about?

NCT00684086 is a clinical study titled "English Diabetes Self-Management Program". We propose a diabetes self-management program evaluation and dissemination project with three components. 1. A six-month randomized trial to evaluate the effect of a community-based small group Diabetes Self Management Program (DSMP) on the health related quality of life, metabolic control and heal...

What is the current status of trial NCT00684086?

This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2007-04.

What conditions does trial NCT00684086 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00684086?

The interventions under investigation include: Diabetes Self Management Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00684086?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00684086 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.